Susan Hasty, Publisher
Table of Contents . . . September 20th, 2009
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Medical Letter on the CDC and FDA | Other Publications
Bioluminescence - New bioluminescence study findings recently were reported by Y.M. Zhang and co-researchers
Campaign for Safe Cosmetics - FDA Study: Lead Levels in Lipstick Much Higher Than Previously Reported
Enzyme Research - Reports on enzyme research findings from R. Gozalbes and co-researchers provide new insights
iTech Medical - Impact Medical Solutions, Inc. dba iTech Medical Engages D&D Securities Company
Life Sciences - Researchers at Brigham and Women's Hospital publish new data on life sciences
Life Sciences - Study results from New York University broaden understanding of life sciences
Thrombocytopenic Purpura Therapy - Research on thrombocytopenic purpura therapy described by scientists at Center for Drug Evaluation and Research
Biowarfare - New biowarfare study results from Meharry Medical College, Medical College described
Cancer - Research from Cambridge University in the area of cancer published
Chemical Warfare - Findings from P.K. Kanaujia and co-authors provide new insights into chemical warfare
Delirium - Studies from S.P. Kruszewse et al further understanding of delirium
Drug Resistance - Data on drug resistance reported by researchers at University of Maryland
Escherichia Coli - Researchers at University of Texas target Escherichia coli
Gastroenterology - Studies in the area of gastroenterology reported from University Hospital
Hantavirus - Study results from University of Sao Paulo update understanding of hantavirus
Hemorrhagic Fever - Studies from Fourth Military Medical University, Medical University Center have provided new information about hemorrhagic fever
Hemorrhagic Fever - Studies from S.R. Sun and co-researchers yield new data on hemorrhagic fever
Human Papillomavirus - Research from B.A. Slade and co-authors reveals new findings on human papillomavirus
Legionnaire Disease - Study results from N.A. Kozak et al provide new insights into legionnaire disease
Life Sciences - Findings from J.M. Nilles et al in life sciences reported
Life Sciences - New findings from D. Steinritz and co-authors in the area of life sciences published
Life Sciences - Research conducted at University of Toronto has provided new information about life sciences
Pandemics - Data from University of Helsinki advance knowledge in pandemics
Pneumonia - Scientists at Oregon Health & Science University release new data on pneumonia
Small-bowel Disease - Data from A. Loscalzo et al provide new insights into small-bowel disease
West Nile Virus - Findings in west nile virus reported from University of Florida
West Nile Virus - Reports from B. Pastorino et al highlight recent research in west nile virus
West Nile Virus - Research on west nile virus discussed by scientists at National Autonomous University
Apoptosis Cell Biology - Researchers at Harbin Medical University, Institute of Public Health target apoptosis cell biology
HIV/AIDS Epidemiology - Investigators at Health Protection Agency Center for Infections have published new data on HIV/AIDS epidemiology
Life Sciences - New findings from University of Tehran, Faculty of Veterinary Medicine in the area of life sciences published
Life Sciences - Reports from University of South Florida add new data to research in life sciences
Life Sciences - Research on life sciences published by scientists at Oregon Health & Science University
Ventricular Assist Devices - Studies from Beth Israel Deaconess Medical Center describe new findings in ventricular assist devices
Allos Therapeutics, Inc. - Allos Therapeutics Announces FDA Advisory Committee Recommends Accelerated Approval of FOLOTYN(TM) pralatrexate for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma
AMAG Pharmaceuticals, Inc. - FDA Decision on Feraheme NDA Expected Within Next Few Days
Anthrax - Advanced Life Sciences' Restanza Demonstrates Efficacy in Treating Anthrax Infection
Anthrax Vaccines - =?ISO-8859-1?Q?PharmAthene_Presents_Data_for_Valort? =?ISO-8859-1?Q QUESTION
Ariba, Inc. - Ariba Offers Remedy for Prescription Drug Ills
Attention Deficit Hyperactivity Disorder - Shire Announces FDA Approval of Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17
Bioengineering - Head of Process Sciences at aTyr Pharma to Speak at Bio Korea 2009
BioNeutral Group, Inc. - BioNeutral and the Chertoff Group Announce a Collaborative Agreement to Continue Development of BioNeutral's Antimicrobial and Sterilant Technologies
Bipolar Disorder - Pfizer Pays a Record Amount to Settle Federal and State Fraud Investigations Into Illegal Off-Label Marketing Practices
Bladder Cancer - Endo Pharmaceuticals Introduces VALSTAR(TM) (Valrubicin) To Fill Unmet Need In Aggressive Form of Bladder Cancer
Cancer - Potential Breakthrough Cancer Treatment Now Available From Vascular Designs
Clinical Trial Research - Cytopia's CYT387 Receives FDA Clearance to Start US Clinical Trials
Commonwealth Brands, Inc. - Commonwealth Brands, Inc. Issues Legal Challenge to FDA
Cordis Corporation - First Patient Enrolled in CYPRESS, a Dual Antiplatelet Therapy Trial with the CYPHER(R) Sirolimus-Eluting Coronary Stent
Cytomegalovirus - FDA Approves Valcyte(R) (valganciclovir hydrochloride) to Prevent Cytomegalovirus (CMV) Disease in Pediatric Patients Who Receive Heart or Kidney Transplants
Diagnostic Hybrids - Diagnostic HYBRIDS Gets FDA Clearance for the Detection of Influenza a H1N1v Virus
Environmental Health - Former AVMA President to Head National Health Commission
Food Poisoning - National Pasteurized Eggs Increases Access to Safe Pasteurized Shell Eggs With New Plant Opening During September's National Food Safety Education Month
Gaucher Disease - Shire Completes Submission of NDA for Velaglucerase Alfa for Type 1 Gaucher Disease and Reports Positive Results for Remaining Two Phase III Trials
Generics - Mylan Launches First Generic Version of Xopenex(R) Inhalation Solution (Concentrate), 0.25%
Genzyme Corporation - FDA Advisory Committee Recommends Randomized Trial to Support Proposed Indication for Clolar in Adult AML
Genzyme Corporation - FDA Advisory Committee to Discuss Genzyme's Clolar for Adult AML on September 1
Hard to Treat Diseases - Hard To Treat Diseases HTDS.PK Stem Cells and Regenerative Medicine
Heparin - Hospira Receives FDA Approval for Six New Presentations of Heparin
Hypogonadism - Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism
Immunization - Sinovac Obtains Production License for H1N1 Vaccine
Knopp Neurosciences Inc. - Knopp Neurosciences Receives FDA Fast Track Designation for KNS-760704 in ALS
Lupus Foundation of America LFA - Shortage of Lupus Patients Challenges Growing Number of Clinical Studies
Medicare and Medicaid - Justice Department Announces Largest Health Care Fraud Settlement in Its History
Medtronic, Inc. - FDA Grants LUCAS(TM) 2 Chest Compression System 510k Clearance in the United States
Mentor Capital, Inc. - New Cancer Immunotherapy Index Posts 23% Gains Lead by Mentor Capital, Inc. and Oncothyreon
Monoclonal Antibodies - Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2010
National Pest Management Association NPMA - Mosquitoes Don't "Fall" Away as a Major Pest Problem When Summer Ends
NeuroLogica Corporation - NeuroLogica Corporation Announces FDA 510k Clearance for inSPira HD: portable high resolution SPECT
Pediatrics - Major Milestone Achieved - Berlin Heart EXCOR Pediatric IDE Study
Peplin, Inc. - Peplin Results for the Financial Year Ended 30 June 2009
Pharmaceuticals - Sheller, P.C. Law Firm Instrumental in Pfizer's $2.3 Billion Settlement Today in Largest Pharmaceutical Whistleblower Case in History
Pharmaceuticals - Vion Pharmaceuticals Announces Results of the Oncologic Drugs Advisory Committee Meeting for Onrigin(TM)
Phillips & Cohen Llp - Bextra Whistleblower Case Started Investigation of Pfizer
POZEN Inc. - POZEN Announces FDA Acceptance of NDA for VIMOVO(TM)
PPD, Inc. - PPD Confirms Takeda Receives FDA Complete Response for Alogliptin
Presbyopia - Abbott to Acquire Visiogen, Expanding Vision Care Portfolio
R.J. Reynolds Tobacco Company - R.J. Reynolds Tobacco Company, Other Tobacco Manufacturers, Retailer, File Suit Challenging Provisions of FDA Tobacco Act
Receptor Logic, Inc. - Receptor Logic, Inc. Awarded National Cancer Institute Grant
Regulatory Actions - Tests Confirm HandClens(R) Hand Sanitizer Kills H1N1 Flu Virus
SignatureForum - Vitality Health LLC Joins HealthySkinPortal Network
Skintastic - Painless, Bruise-free Dermal Filler Injections
Surgery - American Institute for Plastic Surgery is Using Artefill to Fight Patient Wrinkles
Teva Pharmaceutical Industries Ltd. - Teva and Antares Announce FDA Approval of Needle-Free Injector Product for Administration of Tev-Tropin(R) Human Growth Hormone
Thomas Jefferson University - Inhibition of NF-kappa B, a key inflammatory protein, reduced radiation toxicity in zebrafish
ThromboVision, Inc. - ThromboVision to Present at the 11th Annual Rodman & Renshaw Healthcare Conference
U.S. Army Chemical Materials Agency - EPA Approves Army's Closure of Johnston Atoll Chemical Agent Disposal System
U.S. Food and Drug Administration - FDA Study Indicates Most Industry Postmarketing Studies Meet Timelines
Unigene Laboratories, Inc. - U.S. District Court Confirms Validity of Unigene's Fortical(R) Patent
University of California - Los Angeles - Avastin dramatically improves response, survival in deadly recurrrent glioblastomas
University of Rochester Medical Center - Study in NEJM: New therapy prevents heart failure
Vaccines - Sinovac Announces Supply Agreement with Boryung Pharmaceutical Company Limited in South Korea
Vaccines - Which is the Real Terminator of H1N1 Disease, the Antisepsis or the Vaccine?
Varicose Vein - ClariVein(TM) Catheter for Varicose Veins: Clinical Trial Results to be Presented
Wellstone Filter Sciences, Inc. - Wellstone Filter Sciences Applauds FDA Appointment
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.